Toll Free: 0800 201 100
UVRI-CRP Initiative
Toll Free: 0800 201 100
Monday - Friday 9:00 AM - 5:00 PMPlot 51-59 Nakiwogo Road, Entebbe

Advancing health research through clinical trials, basic science, community engagement, education, capacity building, and advocacy.

Contact UsPlot 51-59 Nakiwogo Road, Entebbe, Uganda+256 312 216 100Toll Free: 0800 201 100information@crp.or.ug
Our Research Portfolio

Upcoming Studies

Future research initiatives being prepared for implementation by UVRI-CRP Initiative and its research partners.

Home/Upcoming Studies
Research pipeline

Preparing the next phase of our research portfolio.

Explore upcoming studies being prepared by UVRI-CRP Initiative and its research partners.

Jump to a study
01Schistosomiasis MDA

Optimizing Praziquantel-Based Mass Drug Administration for Schistosomiasis Elimination Using Adjunct Dihydroartemisinin-Piperaquine

Cluster-randomized trialKenyaUganda

A pragmatic multi-country cluster-randomized trial in Kenya and Uganda

The study aims to determine whether Praziquantel with adjunctive dihydroartemisinin-piperaquine mass drug administration can contribute to schistosomiasis elimination as a public health problem. The intended impact is improved health and prosperity in affected communities.

Participating Institutions
  • Uganda Virus Research Institute - Clinical Research Programme Initiative (UVRI-CRP Initiative)
  • African Population and Health Research Center (APHRC)
  • Medical Research Council (MRC)/UVRI & London School of Hygiene and Tropical Medicine (LSHTM) Uganda Research Unit (MUL)
  • Infectious Disease Research Collaboration (IDRC)
  • Ministry of Health Kenya
  • Ministry of Health Uganda